Secretome from mesenchymal stem cells induces angiogenesis via Cyr61

Journal of Cellular Physiology

Volumn 219, Issue 3, 2009, Pages 563-571

  Estrada, Rosendo ^a   Li, Na ^a   Sarojini, Harshini ^a   An, Jin ^a   Lee, Menq Jer ^a   Wang, Eugenia ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE RICH PROTEIN 61; POLYPEPTIDE; PROTEOME; COLLAGEN; CYR61 PROTEIN, MOUSE; LAMININ; MATRIGEL; PROTEOGLYCAN; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL LEVEL; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEIN DETERMINATION; SECRETOME; TISSUE REGENERATION; WOUND HEALING; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG COMBINATION; DRUG EFFECT; ENDOTHELIUM CELL; NUDE MOUSE; PHYSIOLOGY; SECRETION;

ANIMALS; CELLS, CULTURED; COLLAGEN; CULTURE MEDIA, CONDITIONED; CYSTEINE-RICH PROTEIN 61; DRUG COMBINATIONS; ENDOTHELIAL CELLS; HUMANS; LAMININ; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; RECOMBINANT PROTEINS;

EID: 64549107616     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21701     Document Type: Article

References (30)

1. Annabi B, Lee YT, Turcotte S, Naud E, Desrosiers RR, Champagne M, Eliopoulos N, Galipeau J, Beliveau R. 2003. Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells 21:337-347. (Pubitemid 36623175)
2. Babic AM, Kireeva ML, Kolesnikova TV, Lau LF. 1998. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 95:6355-6360. (Pubitemid 28249016)
3. Chamberlain G, Fox J, Ashton B, Middleton J. 2007. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739-2749. (Pubitemid 350127858)
4. Chen Y, Du XY. 2007. Functional properties and intracellular signaling of CCN1/Cyr61. J Cell Biochem 100:1337-1345. (Pubitemid 46515568)
5. Chen NY, Chen CC, Lau LF. 2000. Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans. J Biol Chem 275:24953-24961.
6. Cong Y-S, Fan E, Wang E. 2006. Simultaneous proteomic profiling of four different growth states of human fibroblasts, using amine-reactive isobaric tagging reagents and tandem mass spectrometry. Mech Ageing Dev 127:332-343. (Pubitemid 43290536)
7. Fataccioli V, Abergel V, Wingertsmann L, Neuville P, Spitz E, Adnot S, Calenda V, Teiger E. 2002. Stimulation of angiogenesis by Cyr61 gene: A new therapeutic candidate. Hum Gene Ther 13:1461-1470.
8. Grote K, Salguero G, Ballmaier M, Dangers M, Drexler H, Schieffer B. 2007. The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34(+) progenitor cells: Potential role in angiogenesis and endothelial regeneration. Blood 110:877-885. (Pubitemid 47267424)
9. Hla T, Maciag T. 1990. An abundant transcript induced in differentiating human endothelial-cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J Biol Chem 265:9308-9313. (Pubitemid 20190385)
10. Horwitz EM, Gordon PL, Koo WKK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann T. 2002. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in childrenwith osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932-8937. (Pubitemid 34693661)
11. Iso Y, Spees JL, Serrano C, Bakondi B, Pochampally R, Song YH, Sobel BE, Delafontaine P, Prockop DJ. 2007. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun 354:700-706. (Pubitemid 46186241)
12. Kireeva ML, Lam SCT, Lau LF. 1998. Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin alpha(v)beta(3). J Biol Chem 273:3090-3096. (Pubitemid 28133964)
13. Lau LF, Lam SCT. 1999. The CCN family of angiogenic regulators: The integrin connection. Exp Cell Res 248:44-57. (Pubitemid 29393928)
14. Leask A, Abraham DJ. 2006. All in the CCN family: Essential matricellular signaling modulators emerge from the bunker. J Cell Sci 119:4803-4810. (Pubitemid 46017793)
15. Lee MJ, EvansM, Hla T. 1996. The inducible G protein-coupled receptor edg-1 signals via the G(i)/nitrogen-activated protein kinase pathway. J Biol Chem 271:11272-11279.
16. Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk M, Volpi M, Sha'afi RI, Hla T. 1999. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99:301-312.
17. Mo FE, Muntean AG, Chen CC, Stolz DB, Watkins SC, Lau LF. 2002. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol 22:8709-8720. (Pubitemid 35397184)
18. Obrien TP, Lau LF. 1992. Expression of the growth factor-inducible immediate early gene Cyr61 correlates with chondrogenesis during mouse embryonic-development. Cell Growth Differ 3:645-654.
19. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR. 1992. Methods in laboratory investigation - A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement-membrane, heparin, and fibroblast growth-factor. Lab Invest 67:519-528.
20. Phinney DG. 2007. Biochemical heterogeneity of mesenchymal stem cell populations - Clues to their therapeutic efficacy. Cell Cycle 6:2884-2889.
21. Phinney DG, Prockop DJ. 2007. Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair - Current views. Stem Cells 25:2896-2902. (Pubitemid 350127874)
22. Prockop DJ. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74. (Pubitemid 27161245)
23. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM. 2002. Origin of endothelian progenitors in human postnatal bone marrow. J Clin Invest 109:337-346. (Pubitemid 34141807)
24. Sarojini H, Estrada R, Lu HW, Dekova S, Lee MJ, Gray RD, Wang E. 2008. PEDF from mouse mesenchymal stem cell secretome attracts fibroblasts. J Cell Biochem 104:1793-1802.
25. Schober JM, Chen NY, Grzeszkiewicz TM, Jovanovic I, Emeson EE, Ugarova TP, Ye RD, Lau LF, Lam SCT. 2002. Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): Immediate-early gene products expressed in atherosclerotic lesions. Blood 99:4457-4465.
26. Sze SK, de Kleijn DPV, Lai RC, Tan EKW, Zhao H, Yeo KS, Low TY, Lian Q, Lee CN, Mitchell W, El Oakley RM, Lim SK. 2007. Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol Cell Proteomics 6:1680-1689. (Pubitemid 350031670)
27. Tomanek RJ, Schatteman GC. 2000. Angiogenesis: New insights and therapeutic potential. Anat Rec 261:126-135. (Pubitemid 30451703)
28. Weissman IL. 2000. Translating stem and progenitor cell biology to the clinic: Barriers and opportunities. Science 287:1442-1446. (Pubitemid 30127130)
29. Wu YJ, Chen L, Scott PG, Tredget EE. 2007. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25:2648-2659. (Pubitemid 47582758)
30. Yang GP, Lau LF. 1991. Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular-matrix and the cell-surface. Cell Growth Differ 2:351-357.